Aurobindo Pharma Limited
AUROPHARMA · 524804 · Healthcare · Pharmaceuticals
- Market cap
- Rs 98,508 Cr
- P/E
- 26.75x
- P/B
- 2.60x
- 52W high / low
- Rs 1,740 / Rs 1,066.8
Our computed operating_margin (16.63%) diverges from BSE's own published figure (35.73%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong. Our computed net_margin (10.62%) diverges from BSE's own published figure (24.84%) by more than 100%. BSE's figure is a different, BSE-computed number (not necessarily TTM, standalone-only) — treat as a cross-check/fallback signal, not proof either figure is wrong.
More
Peer comparison
Official BSE basic industry: Pharmaceuticals. Limited to companies within a 0.1x–10x market-cap band.
Edit columns
| Sun Pharmaceutical Industries Limited | Rs 1,865 | Rs 4,44,398 Cr | Rs 62,141 Cr | Rs 12,117 Cr | 36.75x | 15.53% |
| Divi's Laboratories Limited | Rs 9,431 | Rs 2,54,917 Cr | Rs 11,682 Cr | Rs 2,925 Cr | 87.28x | 18.44% |
| Torrent Pharmaceuticals Limited | Rs 4,894 | Rs 1,68,841 Cr | Rs 15,654 Cr | Rs 2,156 Cr | 79.69x | 27.30% |
| Zydus Lifesciences Limited | Rs 1,200.5 | Rs 1,20,149 Cr | Rs 29,052 Cr | Rs 4,593 Cr | 26.83x | 17.68% |
| Cipla Limited | Rs 1,379.3 | Rs 1,13,075 Cr | Rs 29,159 Cr | Rs 3,356 Cr | 33.53x | 10.27% |
| Laurus Labs Limited | Rs 1,979 | Rs 1,08,428 Cr | Rs 7,323 Cr | Rs 1,091 Cr | 99.06x | 22.38% |
| Mankind Pharma Limited | Rs 2,545 | Rs 1,02,213 Cr | Rs 15,062 Cr | Rs 2,068 Cr | 50.01x | 13.50% |
| Dr. Reddy's Laboratories Limited | Rs 1,251.9 | Rs 1,00,284 Cr | Rs 34,651 Cr | Rs 3,183 Cr | 31.04x | 9.02% |
| Aurobindo Pharma LimitedThis company | Rs 1,697.7 | Rs 98,508 Cr | Rs 35,625 Cr | Rs 3,711 Cr | 26.75x | 10.53% |
| Lupin Limited | Rs 2,052.1 | Rs 95,657 Cr | Rs 30,442 Cr | Rs 5,551 Cr | 17.29x | 27.89% |
| Glenmark Pharmaceuticals Limited | Rs 2,441.5 | Rs 67,164 Cr | Rs 18,236 Cr | Rs 1,798 Cr | 37.36x | 15.46% |
| Alkem Laboratories Limited | Rs 5,250 | Rs 63,051 Cr | Rs 15,681 Cr | Rs 2,204 Cr | 29.23x | 16.72% |
| Biocon Limited | Rs 377 | Rs 62,275 Cr | Rs 17,638 Cr | Rs 416 Cr | — | 1.78% |
| Abbott India Limited | Rs 27,270 | Rs 57,279 Cr | Rs 7,295 Cr | Rs 1,615 Cr | 35.47x | 35.85% |
| IPCA Laboratories Limited | Rs 1,938.1 | Rs 49,999 Cr | Rs 10,293 Cr | Rs 1,375 Cr | 38.17x | 17.45% |
| Median | Rs 1,979 | Rs 1,02,213 Cr | Rs 15,681 Cr | Rs 2,925 Cr | 35.47x | 17.45% |
Peers are selected mechanically from the official BSE industry hierarchy and current market-cap band. This is a comparison set, not a ranking or recommendation.